SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001723128-22-000034
Filing Date
2022-08-08
Accepted
2022-08-08 16:42:33
Documents
107
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q amrx-20220630.htm   iXBRL 10-Q 2873238
2 EX-10.1 amrx-2022063010xqexx101.htm EX-10.1 23788
3 EX-31.1 amrx-2022063010xqexx311.htm EX-31.1 10237
4 EX-31.2 amrx-2022063010xqexx312.htm EX-31.2 10363
5 EX-31.3 amrx-2022063010xqexx313.htm EX-31.3 10425
6 EX-32.1 amrx-2022063010xqexx321.htm EX-32.1 5716
7 EX-32.2 amrx-2022063010xqexx322.htm EX-32.2 5662
8 EX-32.3 amrx-2022063010xqexx323.htm EX-32.3 5750
  Complete submission text file 0001723128-22-000034.txt   13734783

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amrx-20220630.xsd EX-101.SCH 95460
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amrx-20220630_cal.xml EX-101.CAL 115803
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amrx-20220630_def.xml EX-101.DEF 504187
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amrx-20220630_lab.xml EX-101.LAB 950748
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amrx-20220630_pre.xml EX-101.PRE 675098
101 EXTRACTED XBRL INSTANCE DOCUMENT amrx-20220630_htm.xml XML 2905316
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38485 | Film No.: 221145039
SIC: 2834 Pharmaceutical Preparations